D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$1.27B |
| 2 |
Meta Platforms (Facebook)
META
|
+$728M |
| 3 |
Microsoft
MSFT
|
+$524M |
| 4 |
T-Mobile US
TMUS
|
+$411M |
| 5 |
Uber
UBER
|
+$406M |
Top Sells
| 1 |
Visa
V
|
+$567M |
| 2 |
Charles Schwab
SCHW
|
+$531M |
| 3 |
Apple
AAPL
|
+$484M |
| 4 |
Johnson & Johnson
JNJ
|
+$455M |
| 5 |
Accenture
ACN
|
+$401M |
Sector Composition
| 1 | Technology | 25.5% |
| 2 | Consumer Discretionary | 13.42% |
| 3 | Healthcare | 12.98% |
| 4 | Financials | 9.15% |
| 5 | Industrials | 7.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Arcellx
ACLX
$4.23B
| $639K | ﹤0.01% |
+20,210
| New | +$639K |
|
2127
Aldeyra Therapeutics
ALDX
$324M
| $637K | ﹤0.01% |
75,980
-48,942
| -39% | -$411K |
|
2128
Lands' End
LE
$475M
| $637K | ﹤0.01% |
82,075
+24,908
| +44% | +$193K |
|
|
KRON
2129
DELISTED
Kronos Bio
KRON
| $636K | ﹤0.01% |
369,878
+53,407
| +17% | +$91.9K |
|
2130
Centrus Energy
LEU
$4.04B
| $634K | ﹤0.01% |
19,484
+7,091
| +57% | +$231K |
|
2131
Reservoir Media, Inc. Warrant
RSVRW
| $631K | ﹤0.01% |
481,924
| – | – |
|
2132
Marcus & Millichap
MMI
$1.26B
| $631K | ﹤0.01% |
20,021
-258
| -1% | -$8.13K |
|
2133
Cal-Maine
CALM
$5.37B
| $631K | ﹤0.01% |
14,017
-96,723
| -87% | -$4.35M |
|
|
CIO
2134
City Office REIT
CIO
$280M
| $630K | ﹤0.01% |
113,186
+8,413
| +8% | +$46.9K |
|
2135
PLDT
PHI
$4.22B
| $628K | ﹤0.01% |
+26,854
| New | +$628K |
|
2136
Bausch + Lomb
BLCO
$5.38B
| $627K | ﹤0.01% |
31,240
-32,597
| -51% | -$654K |
|
2137
Equity Lifestyle Properties
ELS
$11.9B
| $623K | ﹤0.01% |
9,309
-72,183
| -89% | -$4.83M |
|
|
RETA
2138
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $619K | ﹤0.01% |
6,075
-87,341
| -93% | -$8.91M |
|
2139
DXP Enterprises
DXPE
$1.85B
| $619K | ﹤0.01% |
+16,993
| New | +$619K |
|
|
ACB
2140
Aurora Cannabis
ACB
$277M
| $618K | ﹤0.01% |
115,650
-455,889
| -80% | -$2.44M |
|
|
CLVT.PRA
2141
DELISTED
Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares
CLVT.PRA
| $618K | ﹤0.01% |
15,000
| – | – |
|
2142
Paymentus
PAY
$4.1B
| $615K | ﹤0.01% |
58,229
+12,085
| +26% | +$128K |
|
2143
GATX Corp
GATX
$6.05B
| $615K | ﹤0.01% |
4,776
-4,467
| -48% | -$575K |
|
2144
Titan International
TWI
$552M
| $613K | ﹤0.01% |
53,394
-62,091
| -54% | -$713K |
|
2145
XPO
XPO
$15.3B
| $609K | ﹤0.01% |
10,324
-44,330
| -81% | -$2.62M |
|
2146
Acrivon Therapeutics
ACRV
$47.8M
| $608K | ﹤0.01% |
46,910
-14,986
| -24% | -$194K |
|
|
PDS
2147
Precision Drilling
PDS
$765M
| $605K | ﹤0.01% |
12,400
-4,500
| -27% | -$220K |
|
2148
Kimco Realty
KIM
$15.2B
| $605K | ﹤0.01% |
30,673
-648,983
| -95% | -$12.8M |
|
2149
Valero Energy
VLO
$48.7B
| $604K | ﹤0.01% |
5,150
-102,578
| -95% | -$12M |
|
2150
Cable One
CABO
$968M
| $604K | ﹤0.01% |
919
| – | – |
|